Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
CAPN2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAPN2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CAPN1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAPN1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CAMK2G Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAMK2G, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CAMK2D Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAMK2D, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CAMK2B Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAMK2B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CAMK2A Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CAMK2A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CALR Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CALR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CA12 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CA12, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CA9 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CA9, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CA4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CA4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CA2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CA2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
CA1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
20 July 2026
A visual target evaluation report for CA1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.